448 related articles for article (PubMed ID: 17201046)
1. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
[TBL] [Abstract][Full Text] [Related]
2. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
4. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
Jerrell JM; McIntyre RS; Tripathi A
Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
Kilbourne AM; Post EP; Bauer MS; Zeber JE; Copeland LA; Good CB; Pincus HA
J Affect Disord; 2007 Sep; 102(1-3):145-51. PubMed ID: 17276514
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and mental illness.
Newcomer JW
Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
[TBL] [Abstract][Full Text] [Related]
7. Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.
Newcomer JW
J Clin Psychiatry; 2009; 70 Suppl 3():30-6. PubMed ID: 19570499
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk factors among forensic patients in the acute psychiatric ward.
Sazhin V; Reznik R
Aust N Z J Psychiatry; 2008 Mar; 42(3):254. PubMed ID: 18247202
[No Abstract] [Full Text] [Related]
9. Side effects as influencers of treatment outcome.
Sharif Z
J Clin Psychiatry; 2008; 69 Suppl 3():38-43. PubMed ID: 18533761
[TBL] [Abstract][Full Text] [Related]
10. Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia.
Enger C; Jones ME; Kryzhanovskaya L; Doherty M; McAfee AT
Int J Adolesc Med Health; 2013; 25(1):3-11. PubMed ID: 23337048
[TBL] [Abstract][Full Text] [Related]
11. Schizophrenia and obesity: impact of antipsychotic medications.
Wirshing DA
J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
[TBL] [Abstract][Full Text] [Related]
12. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
13. Risk of cardiovascular disease and sudden death in schizophrenia.
Davidson M
J Clin Psychiatry; 2002; 63 Suppl 9():5-11. PubMed ID: 12088174
[TBL] [Abstract][Full Text] [Related]
14. The comorbidity of bipolar disorder and cardiovascular diseases from pharmacotherapy perspective.
Vuksan-Cusa B; Marcinko D; Sagud M; Jakovljević M
Psychiatr Danub; 2009 Sep; 21(3):382-5. PubMed ID: 19794361
[TBL] [Abstract][Full Text] [Related]
15. Metabolic risk during antipsychotic treatment.
Newcomer JW
Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder.
Kilbourne AM; Brar JS; Drayer RA; Xu X; Post EP
Psychosomatics; 2007; 48(5):412-7. PubMed ID: 17878500
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914
[TBL] [Abstract][Full Text] [Related]
18. Understanding needs, interactions, treatment, and expectations among individuals affected by bipolar disorder or schizophrenia: the UNITE global survey.
McIntyre RS
J Clin Psychiatry; 2009; 70 Suppl 3():5-11. PubMed ID: 19570496
[TBL] [Abstract][Full Text] [Related]
19. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
[TBL] [Abstract][Full Text] [Related]
20. Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions.
Megna JL; Schwartz TL; Siddiqui UA; Herrera Rojas M
Ann Clin Psychiatry; 2011 May; 23(2):131-40. PubMed ID: 21547274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
